of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit
Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27
the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or
involves severely illegal business. For example, human trafficking, drug smuggling or money laundering etc. Moreover, the issuer must not act in violation or non-compliance with the law, which may cause
increased tourist-related usage during the festive period in April and May. Competition shifted towards value-based offerings with more personalized packages to gain ARPU. The handset market slowed down in
system of new medicines according to the additional standards SET forth by the Food and Drug administration. Therefore, it is necessary to use the capital to proceed the project amount 32,000,000 baht
personalized packages to drive ARPU. The handset market improved from the previous quarter, fueled by the new iPhone launch. The fixed broadband industry sustained growth despite seasonal challenges during the
tourists. The focus on high-quality acquisition, personalized value-added packages offering at the right time through upselling and cross-selling strategies, and positive impact from package restructuring to
Constructions (2) Registration of 100 drugs formulas (54 formulas for human medicine and 46 formulas for animals) owned by the seller (3) Registration of special drug formulas, consisting of 12 formulas including